These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 25830094)

  • 1. Therapeutic effects of adropin on glucose tolerance and substrate utilization in diet-induced obese mice with insulin resistance.
    Gao S; McMillan RP; Zhu Q; Lopaschuk GD; Hulver MW; Butler AA
    Mol Metab; 2015 Apr; 4(4):310-24. PubMed ID: 25830094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of substrate oxidation preferences in muscle by the peptide hormone adropin.
    Gao S; McMillan RP; Jacas J; Zhu Q; Li X; Kumar GK; Casals N; Hegardt FG; Robbins PD; Lopaschuk GD; Hulver MW; Butler AA
    Diabetes; 2014 Oct; 63(10):3242-52. PubMed ID: 24848071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The peptide hormone adropin regulates signal transduction pathways controlling hepatic glucose metabolism in a mouse model of diet-induced obesity.
    Gao S; Ghoshal S; Zhang L; Stevens JR; McCommis KS; Finck BN; Lopaschuk GD; Butler AA
    J Biol Chem; 2019 Sep; 294(36):13366-13377. PubMed ID: 31324719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adropin regulates cardiac energy metabolism and improves cardiac function and efficiency.
    Altamimi TR; Gao S; Karwi QG; Fukushima A; Rawat S; Wagg CS; Zhang L; Lopaschuk GD
    Metabolism; 2019 Sep; 98():37-48. PubMed ID: 31202835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adropin treatment restores cardiac glucose oxidation in pre-diabetic obese mice.
    Thapa D; Xie B; Zhang M; Stoner MW; Manning JR; Huckestein BR; Edmunds LR; Mullett SJ; McTiernan CF; Wendell SG; Jurczak MJ; Scott I
    J Mol Cell Cardiol; 2019 Apr; 129():174-178. PubMed ID: 30822408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adropin reduces blood glucose levels in mice by limiting hepatic glucose production.
    Thapa D; Xie B; Manning JR; Zhang M; Stoner MW; Huckestein BR; Edmunds LR; Zhang X; Dedousis NL; O'Doherty RM; Jurczak MJ; Scott I
    Physiol Rep; 2019 Apr; 7(8):e14043. PubMed ID: 31004398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adropin regulates pyruvate dehydrogenase in cardiac cells via a novel GPCR-MAPK-PDK4 signaling pathway.
    Thapa D; Stoner MW; Zhang M; Xie B; Manning JR; Guimaraes D; Shiva S; Jurczak MJ; Scott I
    Redox Biol; 2018 Sep; 18():25-32. PubMed ID: 29909017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of energy metabolism by long-chain fatty acids.
    Nakamura MT; Yudell BE; Loor JJ
    Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
    Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
    Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal muscle salt inducible kinase 1 promotes insulin resistance in obesity.
    Nixon M; Stewart-Fitzgibbon R; Fu J; Akhmedov D; Rajendran K; Mendoza-Rodriguez MG; Rivera-Molina YA; Gibson M; Berglund ED; Justice NJ; Berdeaux R
    Mol Metab; 2016 Jan; 5(1):34-46. PubMed ID: 26844205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adropin deficiency is associated with increased adiposity and insulin resistance.
    Ganesh Kumar K; Zhang J; Gao S; Rossi J; McGuinness OP; Halem HH; Culler MD; Mynatt RL; Butler AA
    Obesity (Silver Spring); 2012 Jul; 20(7):1394-402. PubMed ID: 22318315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial infarction in rats causes partial impairment in insulin response associated with reduced fatty acid oxidation and mitochondrial gene expression.
    Amorim PA; Nguyen TD; Shingu Y; Schwarzer M; Mohr FW; Schrepper A; Doenst T
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1160-7. PubMed ID: 20850803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parenteral 17beta-estradiol decreases fasting blood glucose levels in non-obese mice with short-term ovariectomy.
    Kim JY; Jo KJ; Kim OS; Kim BJ; Kang DW; Lee KH; Baik HW; Han MS; Lee SK
    Life Sci; 2010 Sep; 87(11-12):358-66. PubMed ID: 20655933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemia.
    Smith AC; Mullen KL; Junkin KA; Nickerson J; Chabowski A; Bonen A; Dyck DJ
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E172-81. PubMed ID: 17374701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart.
    Dobrzyn P; Sampath H; Dobrzyn A; Miyazaki M; Ntambi JM
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E357-64. PubMed ID: 18042664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of the mammalian pyruvate dehydrogenase kinases in the prevention of hyperglycaemia.
    Sugden MC; Holness MJ
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Jul; 2(2):151-65. PubMed ID: 12476789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
    Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
    Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The AMPK activator R419 improves exercise capacity and skeletal muscle insulin sensitivity in obese mice.
    Marcinko K; Bujak AL; Lally JS; Ford RJ; Wong TH; Smith BK; Kemp BE; Jenkins Y; Li W; Kinsella TM; Hitoshi Y; Steinberg GR
    Mol Metab; 2015 Sep; 4(9):643-51. PubMed ID: 26413470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibition reverses diet-induced obesity, insulin resistance and inflammation in C57BL/6J mice.
    Premaratna SD; Manickam E; Begg DP; Rayment DJ; Hafandi A; Jois M; Cameron-Smith D; Weisinger RS
    Int J Obes (Lond); 2012 Feb; 36(2):233-43. PubMed ID: 21556046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.